ARDT Ardent Health Partners, LLC
Healthcare$9.29+0.65%ClosedMarket Cap: $1.33B
As of 2026-05-26
Valuation
P/E (TTM)
9.90
PEG
—
P/B
0.75
P/S
0.21
EV/EBITDA
3.84
DCF Value
$44.58
FCF Yield
16.2%
Div Yield
0.0%
Margins & Returns
Gross Margin
49.7%
Operating Margin
9.0%
Net Margin
2.1%
ROE
9.1%
ROA
2.6%
ROIC
10.7%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $1.60B | 15.4% | $80.9M | $39.9M | $— | — |
| Q4 null | $1.61B | 42.1% | $104.8M | $45.0M | $— | — |
| FY null | $6.32B | 97.5% | $325.6M | $135.8M | $— | — |
| Q3 null | $1.58B | 57.1% | $254.3M | $-23.5M | $— | — |
| Q2 null | $1.65B | 83.6% | $137.3M | $73.0M | $— | — |
| Q1 null | $1.50B | 82.7% | $67.1M | $41.4M | $— | — |
| Q4 null | $1.61B | 59.3% | $336.8M | $114.2M | $— | — |
| FY null | $5.97B | 82.7% | $405.8M | $210.3M | $— | — |
| Q3 null | $1.45B | 82.6% | $70.4M | $26.3M | $— | — |
| Q2 null | $1.47B | 82.4% | $-157.4M | $42.8M | $— | — |
| Q1 null | $1.44B | 82.1% | $75.8M | $27.0M | $— | — |
| Q4 2023 | $1.35B | 55.6% | $171.9M | $-4.2M | $-0.05 | — |